Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Stada Arzneimittel
Pharma
CapVest snaps up German generics maker Stada
CapVest Partners is set to pick up a majority stake in Stada in a deal that reportedly values the business at around 10 billion euros ($11.6 billion).
Zoey Becker
Sep 2, 2025 10:12am
German generics maker Stada revives IPO plans: report
Aug 28, 2025 1:00pm
Stada charts strong first half of 2024 as owners weigh options
Aug 28, 2024 4:25pm
Stada in 'exploratory' phase of potential sale: CEO
Aug 15, 2023 2:14pm
Stada buys another clutch of consumer health brands from Sanofi
Jul 12, 2023 9:01am
With boost from Romania, Stada breaks ground on $50M plant
Nov 28, 2022 10:05am